Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT00153803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A National Web-Based Randomized Phase III Study of Erlotinib or Placebo Following Concurrent Docetaxel, Carboplatin, and Thoracic Radiotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer (D0410).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a national, randomized, web-based, double-blind study to determine whether erlotinib (Tarceva) compared to placebo improves progression-free survival (PFS) for patients with inoperable, stage III NSCLC following concurrent docetaxel, carboplatin and thoracic radiotherapy. We hypothesize that the introduction of this orally active, well-tolerated agent following concurrent chemoradiation and prior to the emergence of drug resistance will prolong the progression-free survival by 40% (10 months → 14 months).
Study identification
- NCT ID
- NCT00153803
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 245 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2005 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Sep 6, 2019
2005 – 2014
United States locations
- U.S. sites
- 65
- U.S. states
- 28
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology Associates, LLC | Birmingham | Alabama | 35235 | — |
| Oncology Specialties, P.C. | Huntsville | Alabama | 35801 | — |
| Cooper Clinic | Fort Smith | Arkansas | 72913 | — |
| Genesis Cancer Center | Hot Springs | Arkansas | 71913 | — |
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| Northstate Cancer Speciality | Redding | California | 96001 | — |
| Mercy General Hospital | Sacramento | California | 95816 | — |
| St. Francis Hospital Cancer Center | Hartford | Connecticut | 06105 | — |
| Connecticut Oncology Group | Middletown | Connecticut | 06457 | — |
| George Bray Cancer Center/New Britain General Hospital | New Britain | Connecticut | 06050 | — |
| Oncology and Hematology Associates, PC | New London | Connecticut | 06320 | — |
| Whittingham Cancer Center at Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Hematology/Oncology PC/Carl and Dorothy Bennet Cancer Center | Stamford | Connecticut | 06902 | — |
| Washington Cancer Institute | Washington D.C. | District of Columbia | 20010 | — |
| Pasco Hernando Oncology Associates | Brooksville | Florida | 34613 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Lee Cancer Clinic | Fort Myers | Florida | 33919 | — |
| Jupiter Medical Center | Jupiter | Florida | 33458 | — |
| Cancer Care of North Florida | Lake City | Florida | 32055 | — |
| Pasco/Hernando Oncology | New Port Richey | Florida | 34652 | — |
| Mid Florida Oncology | Orange City | Florida | 32763 | — |
| MD Anderson | Orlando | Florida | 32806 | — |
| Oncology & Hematology Association of West Broward | Tamarac | Florida | 33321 | — |
| Palm Beach Cancer Institute | West Palm Beach | Florida | 33410 | — |
| Alexian Brothers Hospital Network | Elk Grove Village | Illinois | 60007 | — |
| Joliet Hematology Associates | Joliet | Illinois | 60435 | — |
| Investigative Clinical Research of Indiana LLC | Indianapolis | Indiana | 46254 | — |
| Howard Regional Health System | Kokomo | Indiana | 46904 | — |
| McFarland Clinic | Ames | Iowa | 50010 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| Western Hematology Oncology | Paducah | Kentucky | 42003 | — |
| Maine Center for Cancer Medicine | Scarborough | Maine | 04074 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Union Memorial Hospital | Baltimore | Maryland | 21218 | — |
| Harbor View Cancer Center | Baltimore | Maryland | 21225 | — |
| Franklin Square Hospital Center | Baltimore | Maryland | 21237 | — |
| Frederick Smith, MD | Chevy Chase | Maryland | 20815 | — |
| Community Hematology Oncology | Olney | Maryland | 20832 | — |
| Lahey Clinic Medical Center | Burlington | Massachusetts | 01805 | — |
| Fallon Clinic Hematology/ Oncology | Worcester | Massachusetts | 01608 | — |
| Bay Medical Cancer Center | Bay City | Michigan | 48706 | — |
| Southeast Nebraska Hematology/Oncology | Lincoln | Nebraska | 68510 | — |
| Methodist Cancer Center | Omaha | Nebraska | 68114 | — |
| Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Dartmouth-Hitchcock-Keene | Keene | New Hampshire | 03431 | — |
| Norris Cotton Cancer Center | Lebanon | New Hampshire | 03756 | — |
| The Center for Cancer and Hematologic Disease | Cherry Hill | New Jersey | 00000 | — |
| Sussex County Medical Associates | Newton | New Jersey | 07860 | — |
| Queens Medical Associates | Fresh Meadows | New York | 11365 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Hematology Oncology Associates of Rockland, PC | New York | New York | 10956 | — |
| Lincoln Hospital | The Bronx | New York | 10451 | — |
| Southeastern Medical Oncology Center | Goldsboro | North Carolina | 27534 | — |
| Aultman Cancer Center | Canton | Ohio | 44710 | — |
| The Cleveland Clinic Foundation Hematology/Med Oncology | Cleveland | Ohio | 44195 | — |
| Legacy Good Samaritan | Portland | Oregon | 97201 | — |
| SCOA-SC Onc Assoc | Columbia | South Carolina | 29201 | — |
| VA Department of Hematology/Oncology | Houston | Texas | 77030 | — |
| Hope Oncology | Richardson | Texas | 75080 | — |
| Blood and Cancer Center of East Texas | Tyler | Texas | 75701 | — |
| Tyler Hematology/Oncology | Tyler | Texas | 75701 | — |
| Veterans Administration Medical Center | White River Junction | Vermont | 05009 | — |
| Virginia Oncology Associates Research Program | Newport News | Virginia | 23606 | — |
| Olympic Hematology/Oncology | Bremerton | Washington | 98310 | — |
| Morgantown Internal Medicine Group | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00153803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 6, 2019 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00153803 live on ClinicalTrials.gov.